semaglutide brown fat Semaglutide: What It Is, Mechanisms of Action, Use in Obesity Visceral Fat Loss with Semaglutide:

In this study, the potential effects of GLP-1RAs on the occurrence and development of tumors were reviewed to provide new ideas for the prevention and treatment of tumors in patients

All sensitivity analyses (i.e., using a strict definition [stable use] for previous or current users of GLP-1RAs or SGLT2is, excluding the TZD effect, using the lag-time approach, and refining the treatment exposure period as 2 years before the index date) yielded results that are consistent with the primary findings, showing a decreased but insignificant risk of NAFLD/NASH events with the use of GLP-1RAs or SGLT-2is (Fig

Evidence for a lobular- and laminar-specific dopamine innervation

With 100 mg and 300 mg of canagliflozin, incidence rates were reported as 0.52 and 0.76 per 1000 patient/yr respectively

Abrams et al